- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06260332
Intervento sull'attività fisica per il miglioramento del dolore nei giovani sopravvissuti al cancro al seno ispanici
Verso il recupero: un intervento di attività fisica per ridurre il dolore persistente dopo un intervento chirurgico al seno per cancro in donne giovani e ispaniche
This clinical trial tests whether increased activity throughout the day can improve the chronic pain and associated symptoms that breast cancer survivors may experience after surgery. Staying active is a key factor of one's physical, mental, and social health and well-being. Moving more could also reduce pain and associated stress, anxiety, or depression. Using a fitness tracker may help patients to move around more, whether or not they choose to exercise. Information gathered from this study may help researchers learn how the use of a Fitbit tracker with health coaching may improve physical activity and reduce pain in young, Hispanic breast cancer survivors.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
PRIMARY OBJECTIVE:
I. To assess the feasibility of a physical activity intervention in young, Hispanic women with chronic post-operative pain after breast surgery for invasive breast cancer, termed post breast surgery pain syndrome (PBSPS) for this study.
SECONDARY OBJECTIVES:
I. To assess the preliminary efficacy of a physical activity intervention in decreasing pain in young, Hispanic women with PBSPS.
II. To assess the preliminary efficacy of the physical activity intervention in increasing physical activity and improving health-related quality of life (hrQOL).
OUTLINE:
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87106
- University of New Mexico Comprehensive Cancer Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Women who have completed surgery for invasive breast cancer >= 6 months prior to enrollment
- Any breast surgery (lumpectomy or mastectomy)
- Baseline low to moderate activity level (exercise less than 120 minutes a week)
- PBSPS defined as pain in the area of breast surgery of at least moderate intensity (>= 4 on a scale of 1-10), located in the ipsilateral beast/chest wall, axilla or arm, lasting at least 6 months, and occurring at least 50% of the time
- Self-identified as Hispanic/Latinx
- Age, >= 18 and =< 60 years
- Endocrine therapy and ovarian suppression is allowed
Exclusion Criteria:
- Metastatic or locally recurrent disease with no option for curative intent treatment
- Meeting or exceeding physical activity guidelines (> 150 minutes per week of moderate-intensity exercise)
- Unable to speak, read, and understand English or Spanish
- Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily physical activity. This is defined as the ability to walk 3 blocks without stopping to rest and without using an assistive device
- Unwilling to use a study provided smartphone (if do not already own one) and wear activity trackers/monitors
- Adults not able to consent are excluded from participation
- Based on the age criteria (18 years and older), individuals who are not yet adults (infants, children, teenagers) may not participate in this study due to the same age criteria above
- Pregnant women
- Prisoners may not participate in this study as this is a study of free-living individuals
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Supportive Care (Fitbit)
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11. |
Wear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Recruitment rate (Feasibility)
Lasso di tempo: Up to 1 year
|
This study will be considered feasible with the recruitment of 25 breast cancer patients. |
Up to 1 year
|
|
Retention rate (Feasibility)
Lasso di tempo: Up to 12 weeks
|
This study will be considered feasible if 80% of patients complete all pre and post assessments. |
Up to 12 weeks
|
|
Adherence rate (Feasibility)
Lasso di tempo: Up to 12 weeks
|
This study will be considered feasible if participants complete at least 4 of 5 health coaching sessions (80%). |
Up to 12 weeks
|
|
Incidence of adverse events
Lasso di tempo: Up to 12 weeks
|
Safety will be tracked by the study team. |
Up to 12 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in chronic post-surgical pain
Lasso di tempo: At 13 weeks
|
Reducing chronic post-surgical pain will be measured using the Defense and Veterans Pain Rating Scale. Will also be assessed by Bodily Threat Monitoring Scale and pain self-efficacy questionnaire. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests. |
At 13 weeks
|
|
Change in physical activity
Lasso di tempo: At 13 weeks
|
Increasing physical activity will be measured using accelerometry data using the activePAL activity monitor. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests. |
At 13 weeks
|
|
Change in health-related quality of life (hrQOL)
Lasso di tempo: At 13 weeks
|
Improvement in hrQOL will be measured using Patient-Reported Outcomes Measurement Information System surveys. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests. |
At 13 weeks
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Jacklyn M Nemunaitis, MD, New Mexico Cancer Research Alliance
- Investigatore principale: Cindy K Blair, Ph.D., New Mexico Cancer Research Alliance
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Neoplasie per sede
- Neoplasie
- Malattie della pelle
- Malattie del seno
- Malattie della pelle e del tessuto connettivo
- Neoplasie mammarie
- Terapie
- Cura del paziente
- Servizi sanitari
- Force di lavoro e servizi per le strutture sanitarie
- Servizi sanitari della comunità
- Discipline e attività comportamentali
- Servizi di salute mentale
- Cure palliative
- Consulenza
Altri numeri di identificazione dello studio
- INST UNM 2302
- 23-293 (Altro identificatore: UNM HSC IRB)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .